International Stem Cell Corporation (ISCO)

International Stem Cell Revenue

International Stem Cell had revenue of $2.68M in the quarter ending June 30, 2026, with 9.32% growth. This brings the company's total for the last twelve months to $9.51M, up 3.40% year-over-year. In the year 2025, International Stem Cell had annual revenue of $9.10M with 0.17% growth. That makes International Stem Cell the 37,577th largest company in the world by revenue and 4,933rd in the United States.

• Revenue (ttm): 9.51M
• Revenue Growth: +3.40%
• P/S Ratio: 0.12
• Revenue / Employee: 288.30K
• Employees: 33
• Market Cap: 1.13M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biomedical Market (LCT) 8.50M 93.4%
• Anti-Aging Market (LSC) 598.00K 6.6%

By Geography

Chart

• United States (US) 7.84M 86.1%
• Asia 719.00K 7.9%
• Europe 448.00K 4.9%
• All Other Regions 95.00K 1.0%

Fiscal year ended Dec 31, 2025 See the full International Stem Cell breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.10M	15.00K	0.17%
Dec 31, 2024	9.09M	1.30M	16.64%
Dec 31, 2023	7.79M	-391.00K	-4.78%
Dec 31, 2022	8.18M	1.00M	13.99%
Dec 31, 2021	7.18M	48.00K	0.67%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error